| 37.34 Net Asset Value | -0.19% 1 Day | +22.51% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 1.18% Expense Ratio | Average Morningstar Risk Rating™ |
| 1 month | +3.92% | 3 years | +19.80% | |
| 3 months | +12.92% | 5 years | +9.66% | |
| 1 year | +38.36% | Since inception | +7.73% |
| GTHIX | Category | |
|---|---|---|
| Performance 5-yr return | +9.66% | +12.10% |
| Expense ratio | 1.18% | 1.55% |
| Risk 5 year sharpe ratio | 0.60 | 0.71 |
| Net assets | $1.3B | $1.5B |
| Average market cap | $22.3B | $19.4B |
| Average P/E | 17.1 | 21.6 |
| Portfolio turnover | 39% | 39% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | Invesco |
| Fund manager & tenure | Derek Taner / 8 Years |
| Minimal initial investment | $1,000.00 |
| Minimum IRA investment | $250.00 |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 93.05% |
| Consumer service | 4.85% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Energy | 0.00% |
| PFE Pfizer Inc | 4.79% |
| -- Roche Holding AG | 4.65% |
| NVS Novartis AG ADR | 4.26% |
| JNJ Johnson & Johnson | 4.20% |
| ABT Abbott Laboratories | 3.84% |
| GILD Gilead Sciences Inc | 3.29% |
| SNY Sanofi ADR | 3.05% |
| -- Bayer AG | 2.79% |
| SHPG Shire PLC ADR | 2.57% |
| MCK McKesson, Inc. | 2.51% |
.
